|
|
|
|
|
by bdowling
907 days ago
|
|
That would be the obvious solution, but it’s not surprising they couldn’t agree on a price when they operate in very different industries. Masimo makes medical devices, ones whose prices are probably both high and skewed by insurance. Apple is a consumer devices company and may not be able to justify a high royalty price and still meet certain consumer price points. Another possibility is that Apple’s watches may be an alternative to Masimo’s expensive, high-margin devices, so a licensing deal could destroy Masimo’s entire business in the long run. So, coming to an agreement on price may have been impossible. |
|
That $8 pulse oximeter from aliexpress is better than nothing, but it’s a long way from what Masimo or Medtronic (Nellcor) sell.
And the prices for oximeters aren’t really affected by insurance, as individuals almost never get them at diagnostic grade. They’re durable, have screens that convey more than just a number, electrically isolated from the patient… there’s a lot going on there that is not, at first glance, obvious to the layman.
(I’m an anesthesiologist; pulse oximetry with a good waveform display is a critical monitor for us. I would rather have a good pulse ox than any other non-invasive monitor, if I could only have one.)